Suresh Ramalingam

Professor, Director of Medical Oncology

Emory University

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (16)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (7)

Gerald Falchook

UNITED STATES

View details

Shi-Yong Sun

Professor

Emory University

UNITED STATES

View details

Silvia NOVELLO

Professor

Università degli Studi di Torino

ITALY

View details

Gordon Freeman

Professor

Dana-Farber Cancer Institute

UNITED STATES

View details

Francesco Gelsomino

ALMA MATER STUDIORUM UNIVERSITY OF BOLOGNA

ITALY

View details

ENRIQUETA FELIP

Head Thoracic Oncology Unit (After Competitive Exam)

Hospital Universitari Vall d'Hebron

SPAIN

View details

Qiming Wang

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Suresh Ramalingam

Research Interests

Explore related searches

Contact this professor

Articles (16)

Inhibition of hTERT/telomerase/telomere mediates therapeutic efficacy of osimertinib in EGFR mutant lung cancer

Encorafenib plus binimetinib for BRAF V600E-mutant metastatic NSCLC: clinical implications of the phase 2 PHAROS study

The MARIPOSA trials — implications for the treatment of EGFR-mutant NSCLC

Direct to Cancer: A new initiative to enhance the author experience

Commemorating the 20th anniversary of the discovery of epidermal growth factor receptor mutation in lung cancer: Translational research at its best

DNA topoisomerase II inhibition potentiates osimertinib’s therapeutic efficacy in EGFR-mutant non–small cell lung cancer models

Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated KRAS G12C-Mutated Non–Small-Cell Lung Cancer: 2-Year Analysis of CodeBreaK 100

Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With BRAFV600-Mutant Metastatic Non–Small-Cell Lung Cancer

Cancer Turns 75!

Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trial

mTOR regulates T cell exhaustion and PD-1–targeted immunotherapy response during chronic viral infection

Lung-MAP: A Collaborative Roadmap to Improve Cancer Outcomes

Encorafenib plus binimetinib in patients with BRAFV600-mutant non-small cell lung cancer: phase II PHAROS study design

JASPER: Phase 2 trial of first‐line niraparib plus pembrolizumab in patients with advanced non–small cell lung cancer

The National Cancer Act of 1971: A seminal milestone in the fight against cancer

Veliparib in Combination With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III Study

Collaborators (7)

Gerald Falchook

Shi-Yong Sun

Silvia NOVELLO

Gordon Freeman

Francesco Gelsomino

ENRIQUETA FELIP

Qiming Wang

Make your next move.